Home › Companies › NOVOCURE LTD. › 2024-2025
Compiled from SEC Form N-PX filings and NOVOCURE LTD.’s Form 8-K (Item 5.07 on EDGAR). Page generated 04 October 2026.
Explore NOVOCURE LTD. in the interactive database Compare manager voting policies
These tallies are NOVOCURE LTD.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Ashley Cordova | 82,362,437 | 340,654 | 228,785 | -- | 10,049,703 | Majority: yes |
| Elect Director: Asaf Danziger | 81,932,893 | 745,479 | 253,504 | -- | 10,049,703 | Majority: yes |
| Elect Director: William Doyle | 81,900,273 | 800,682 | 230,921 | -- | 10,049,703 | Majority: yes |
| Elect Director: Jeryl Hilleman | 82,196,663 | 494,915 | 240,298 | -- | 10,049,703 | Majority: yes |
| Elect Director: David Hung | 82,142,624 | 531,558 | 257,694 | -- | 10,049,703 | Majority: yes |
| Elect Director: Kinyip Gabriel Leung | 81,198,024 | 1,499,970 | 233,882 | -- | 10,049,703 | Majority: yes |
| Elect Director: Martin Madden | 82,199,569 | 497,393 | 234,914 | -- | 10,049,703 | Majority: yes |
| Elect Director: Allyson Ocean | 82,147,906 | 527,676 | 256,294 | -- | 10,049,703 | Majority: yes |
| Elect Director: Timothy Scannell | 82,199,320 | 495,578 | 236,978 | -- | 10,049,703 | Majority: yes |
| Elect Director: Kristin Stafford | 82,206,597 | 490,733 | 234,546 | -- | 10,049,703 | Majority: yes |
| Elect Director: William Vernon | 81,646,756 | 1,048,764 | 236,356 | -- | 10,049,703 | Majority: yes |
| Proposal 2: Ratification of Independent Registered Public Accounting Firm . | 91,489,770 | 1,216,673 | 275,136 | -- | -- | Passed |
| Proposal 3: Approval of a non-binding advisory vote to approve executive compensation . | 80,626,467 | 2,042,002 | 263,407 | -- | 10,049,703 | Passed |
| Proposal 4: Approval of the Company's 2025 Employee Share Purchase Plan . | 82,005,031 | 684,858 | 241,987 | -- | 10,049,703 | Passed |
Source: NOVOCURE LTD., Form 8-K — read the filing on EDGAR.
Each item below shows how the 273 asset managers that disclosed a NOVOCURE LTD. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of NOVOCURE LTD.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held 2025-06-04.
Combines 6 wordings of this item as funds reported it.
98% Passed · of votes cast
NOVOCURE LTD.’s own tally for this item (“Proposal 3: Approval of a non-binding advisory vote to approve executive compensation .”): 80,626,467 for, 2,042,002 against — passed, per its Form 8-K (Item 5.07). Of all 111,482,600 outstanding shares: 72% for, 2% against (74% of the company cast a for/against vote).
The 262 asset managers below cast 98% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 27,801,718 | 0 | 0 | 0 | For |
| Fidelity | 27,557,831 | 0 | 0 | 0 | For |
| BlackRock | 12,727,088 | 22,825 | 0 | 0 | For |
| Vanguard | 11,306,808 | 892 | 0 | 0 | For |
| Soleus Capital Management, L.P. | 5,451,639 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,474,102 | 0 | 0 | 0 | For |
| State Street | 2,366,669 | 0 | 0 | 0 | For |
| Charles Schwab | 1,635,753 | 0 | 0 | 0 | For |
| Northern Trust | 1,175,040 | 0 | 0 | 0 | For |
| Palo Alto Investors LP | 956,589 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 944,643 | 0 | 0 | 0 | For |
| T. Rowe Price | 882,809 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD & CO LTD | 747,398 | 0 | 0 | 0 | For |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 650,119 | 0 | 0 | 0 | For |
| C WorldWide Asset Management Fondsmaeglerselskab A/S | 0 | 621,784 | 0 | 0 | Against |
| Nuveen | 572,507 | 0 | 0 | 0 | For |
| UBS | 570,273 | 0 | 0 | 0 | For |
| TIAA | 562,136 | 0 | 0 | 0 | For |
| Granite Investment Partners, LLC | 561,123 | 0 | 0 | 0 | For |
| BALYASNY ASSET MANAGEMENT L.P. | 430,795 | 0 | 0 | 0 | For |
| Renaissance | 389,422 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 383,179 | 0 | 0 | 0 | For |
| Federated Hermes | 349,277 | 0 | 0 | 0 | For |
| EMERALD MUTUAL FUND ADVISERS TRUST | 323,960 | 0 | 0 | 0 | For |
| Equitable | 307,448 | 0 | 0 | 0 | For |
Showing the 25 largest of 262 asset managers. See all 262 in the interactive database.
Meeting held 2025-06-04.
Combines 2 wordings of this item as funds reported it.
99.1% Passed · of votes cast
NOVOCURE LTD.’s own tally for this item (“Proposal 4: Approval of the Company's 2025 Employee Share Purchase Plan .”): 82,005,031 for, 684,858 against — passed, per its Form 8-K (Item 5.07). Of all 111,482,600 outstanding shares: 74% for, 0.7% against (74% of the company cast a for/against vote).
The 62 asset managers below cast 99.9% of the shares they voted on this item FOR (46,164,419 for, 43,768 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 13,635,991 | 0 | 0 | 0 | For |
| Fidelity | 11,071,645 | 0 | 0 | 0 | For |
| Vanguard | 10,899,399 | 0 | 0 | 0 | For |
| BlackRock | 6,352,641 | 0 | 0 | 0 | For |
| Charles Schwab | 817,862 | 0 | 0 | 0 | For |
| TIAA | 562,136 | 0 | 0 | 0 | For |
| T. Rowe Price | 324,424 | 0 | 0 | 0 | For |
| Equitable | 307,448 | 0 | 0 | 0 | For |
| State Street | 185,151 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 181,491 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 164,792 | 0 | 0 | 0 | For |
| Lincoln Financial | 145,820 | 0 | 0 | 0 | For |
| Principal | 125,069 | 0 | 0 | 0 | For |
| Federated Hermes | 120,195 | 0 | 0 | 0 | For |
| DWS | 112,506 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 105,000 | 0 | 0 | 0 | For |
| American Century | 93,085 | 0 | 0 | 0 | For |
| Global X | 75,363 | 0 | 0 | 0 | For |
| Brighthouse | 40,548 | 16,878 | 0 | 0 | For |
| AIG/SunAmerica | 55,259 | 0 | 0 | 0 | For |
| Northern Trust | 53,735 | 0 | 0 | 0 | For |
| Putnam | 53,024 | 0 | 0 | 0 | For |
| John Hancock | 46,340 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 44,762 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 42,933 | 0 | 0 | 0 | For |
Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.
Meeting held 2025-06-04.
Combines 2 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
NOVOCURE LTD.’s own tally for this item (“Elect Director: Ashley Cordova”): 82,362,437 for, 340,654 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 111,482,600 outstanding shares: 74% for, 0.4% against (74% of the company cast a for/against vote).
The 61 asset managers below cast 99.9% of the shares they voted on this item FOR (46,191,085 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 13,635,991 | 0 | 0 | 0 | For |
| Fidelity | 11,071,645 | 0 | 0 | 0 | For |
| Vanguard | 10,899,399 | 0 | 0 | 0 | For |
| BlackRock | 6,352,641 | 0 | 0 | 0 | For |
| Charles Schwab | 817,862 | 0 | 0 | 0 | For |
| TIAA | 562,136 | 0 | 0 | 0 | For |
| T. Rowe Price | 324,424 | 0 | 0 | 0 | For |
| Equitable | 307,448 | 0 | 0 | 0 | For |
| State Street | 185,151 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 181,491 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 164,792 | 0 | 0 | 0 | For |
| Lincoln Financial | 145,820 | 0 | 0 | 0 | For |
| Principal | 125,069 | 0 | 0 | 0 | For |
| Federated Hermes | 120,195 | 0 | 0 | 0 | For |
| DWS | 112,506 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 105,000 | 0 | 0 | 0 | For |
| American Century | 93,085 | 0 | 0 | 0 | For |
| Global X | 75,363 | 0 | 0 | 0 | For |
| Brighthouse | 40,548 | 0 | 16,878 | 0 | For |
| AIG/SunAmerica | 55,259 | 0 | 0 | 0 | For |
| Northern Trust | 53,735 | 0 | 0 | 0 | For |
| Putnam | 53,024 | 0 | 0 | 0 | For |
| John Hancock | 46,340 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 44,762 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 42,933 | 0 | 0 | 0 | For |
Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.
Meeting held 2025-06-04.
Combines 2 wordings of this item as funds reported it.
99.0% Majority: yes · of votes cast
NOVOCURE LTD.’s own tally for this item (“Elect Director: Asaf Danziger”): 81,932,893 for, 745,479 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 111,482,600 outstanding shares: 73% for, 0.7% against (74% of the company cast a for/against vote).
The 61 asset managers below cast 99.9% of the shares they voted on this item FOR (46,191,085 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 13,635,991 | 0 | 0 | 0 | For |
| Fidelity | 11,071,645 | 0 | 0 | 0 | For |
| Vanguard | 10,899,399 | 0 | 0 | 0 | For |
| BlackRock | 6,352,641 | 0 | 0 | 0 | For |
| Charles Schwab | 817,862 | 0 | 0 | 0 | For |
| TIAA | 562,136 | 0 | 0 | 0 | For |
| T. Rowe Price | 324,424 | 0 | 0 | 0 | For |
| Equitable | 307,448 | 0 | 0 | 0 | For |
| State Street | 185,151 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 181,491 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 164,792 | 0 | 0 | 0 | For |
| Lincoln Financial | 145,820 | 0 | 0 | 0 | For |
| Principal | 125,069 | 0 | 0 | 0 | For |
| Federated Hermes | 120,195 | 0 | 0 | 0 | For |
| DWS | 112,506 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 105,000 | 0 | 0 | 0 | For |
| American Century | 93,085 | 0 | 0 | 0 | For |
| Global X | 75,363 | 0 | 0 | 0 | For |
| Brighthouse | 40,548 | 0 | 16,878 | 0 | For |
| AIG/SunAmerica | 55,259 | 0 | 0 | 0 | For |
| Northern Trust | 53,735 | 0 | 0 | 0 | For |
| Putnam | 53,024 | 0 | 0 | 0 | For |
| John Hancock | 46,340 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 44,762 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 42,933 | 0 | 0 | 0 | For |
Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.
Meeting held 2025-06-04.
Combines 2 wordings of this item as funds reported it.
99.0% Majority: yes · of votes cast
NOVOCURE LTD.’s own tally for this item (“Elect Director: William Doyle”): 81,900,273 for, 800,682 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 111,482,600 outstanding shares: 73% for, 0.8% against (74% of the company cast a for/against vote).
The 61 asset managers below cast 99.9% of the shares they voted on this item FOR (46,189,759 for, 1,326 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 13,635,991 | 0 | 0 | 0 | For |
| Fidelity | 11,071,645 | 0 | 0 | 0 | For |
| Vanguard | 10,898,507 | 892 | 0 | 0 | For |
| BlackRock | 6,352,641 | 0 | 0 | 0 | For |
| Charles Schwab | 817,862 | 0 | 0 | 0 | For |
| TIAA | 562,136 | 0 | 0 | 0 | For |
| T. Rowe Price | 324,424 | 0 | 0 | 0 | For |
| Equitable | 307,448 | 0 | 0 | 0 | For |
| State Street | 185,151 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 181,491 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 164,792 | 0 | 0 | 0 | For |
| Lincoln Financial | 145,820 | 0 | 0 | 0 | For |
| Principal | 125,069 | 0 | 0 | 0 | For |
| Federated Hermes | 120,195 | 0 | 0 | 0 | For |
| DWS | 112,506 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 105,000 | 0 | 0 | 0 | For |
| American Century | 93,085 | 0 | 0 | 0 | For |
| Global X | 75,363 | 0 | 0 | 0 | For |
| Brighthouse | 40,548 | 0 | 16,878 | 0 | For |
| AIG/SunAmerica | 55,259 | 0 | 0 | 0 | For |
| Northern Trust | 53,735 | 0 | 0 | 0 | For |
| Putnam | 53,024 | 0 | 0 | 0 | For |
| John Hancock | 46,340 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 44,762 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 42,933 | 0 | 0 | 0 | For |
Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.
Meeting held 2025-06-04.
Combines 2 wordings of this item as funds reported it.
99.4% Majority: yes · of votes cast
NOVOCURE LTD.’s own tally for this item (“Elect Director: Jeryl Hilleman”): 82,196,663 for, 494,915 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 111,482,600 outstanding shares: 74% for, 0.5% against (74% of the company cast a for/against vote).
The 61 asset managers below cast 99.9% of the shares they voted on this item FOR (46,191,085 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 13,635,991 | 0 | 0 | 0 | For |
| Fidelity | 11,071,645 | 0 | 0 | 0 | For |
| Vanguard | 10,899,399 | 0 | 0 | 0 | For |
| BlackRock | 6,352,641 | 0 | 0 | 0 | For |
| Charles Schwab | 817,862 | 0 | 0 | 0 | For |
| TIAA | 562,136 | 0 | 0 | 0 | For |
| T. Rowe Price | 324,424 | 0 | 0 | 0 | For |
| Equitable | 307,448 | 0 | 0 | 0 | For |
| State Street | 185,151 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 181,491 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 164,792 | 0 | 0 | 0 | For |
| Lincoln Financial | 145,820 | 0 | 0 | 0 | For |
| Principal | 125,069 | 0 | 0 | 0 | For |
| Federated Hermes | 120,195 | 0 | 0 | 0 | For |
| DWS | 112,506 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 105,000 | 0 | 0 | 0 | For |
| American Century | 93,085 | 0 | 0 | 0 | For |
| Global X | 75,363 | 0 | 0 | 0 | For |
| Brighthouse | 40,548 | 0 | 16,878 | 0 | For |
| AIG/SunAmerica | 55,259 | 0 | 0 | 0 | For |
| Northern Trust | 53,735 | 0 | 0 | 0 | For |
| Putnam | 53,024 | 0 | 0 | 0 | For |
| John Hancock | 46,340 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 44,762 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 42,933 | 0 | 0 | 0 | For |
Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.
Meeting held 2025-06-04.
Combines 2 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
NOVOCURE LTD.’s own tally for this item (“Elect Director: David Hung”): 82,142,624 for, 531,558 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 111,482,600 outstanding shares: 74% for, 0.5% against (74% of the company cast a for/against vote).
The 61 asset managers below cast 99.9% of the shares they voted on this item FOR (46,191,085 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 13,635,991 | 0 | 0 | 0 | For |
| Fidelity | 11,071,645 | 0 | 0 | 0 | For |
| Vanguard | 10,899,399 | 0 | 0 | 0 | For |
| BlackRock | 6,352,641 | 0 | 0 | 0 | For |
| Charles Schwab | 817,862 | 0 | 0 | 0 | For |
| TIAA | 562,136 | 0 | 0 | 0 | For |
| T. Rowe Price | 324,424 | 0 | 0 | 0 | For |
| Equitable | 307,448 | 0 | 0 | 0 | For |
| State Street | 185,151 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 181,491 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 164,792 | 0 | 0 | 0 | For |
| Lincoln Financial | 145,820 | 0 | 0 | 0 | For |
| Principal | 125,069 | 0 | 0 | 0 | For |
| Federated Hermes | 120,195 | 0 | 0 | 0 | For |
| DWS | 112,506 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 105,000 | 0 | 0 | 0 | For |
| American Century | 93,085 | 0 | 0 | 0 | For |
| Global X | 75,363 | 0 | 0 | 0 | For |
| Brighthouse | 40,548 | 0 | 16,878 | 0 | For |
| AIG/SunAmerica | 55,259 | 0 | 0 | 0 | For |
| Northern Trust | 53,735 | 0 | 0 | 0 | For |
| Putnam | 53,024 | 0 | 0 | 0 | For |
| John Hancock | 46,340 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 44,762 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 42,933 | 0 | 0 | 0 | For |
Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.
Meeting held 2025-06-04.
Combines 2 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
NOVOCURE LTD.’s own tally for this item (“Elect Director: Kinyip Gabriel Leung”): 81,198,024 for, 1,499,970 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 111,482,600 outstanding shares: 73% for, 1% against (74% of the company cast a for/against vote).
The 61 asset managers below cast 99.9% of the shares they voted on this item FOR (46,153,054 for, 38,031 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 13,635,991 | 0 | 0 | 0 | For |
| Fidelity | 11,071,645 | 0 | 0 | 0 | For |
| Vanguard | 10,899,399 | 0 | 0 | 0 | For |
| BlackRock | 6,352,641 | 0 | 0 | 0 | For |
| Charles Schwab | 817,862 | 0 | 0 | 0 | For |
| TIAA | 562,136 | 0 | 0 | 0 | For |
| T. Rowe Price | 324,424 | 0 | 0 | 0 | For |
| Equitable | 307,448 | 0 | 0 | 0 | For |
| State Street | 185,151 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 181,491 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 164,792 | 0 | 0 | 0 | For |
| Lincoln Financial | 145,820 | 0 | 0 | 0 | For |
| Principal | 125,069 | 0 | 0 | 0 | For |
| Federated Hermes | 120,195 | 0 | 0 | 0 | For |
| DWS | 112,506 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 105,000 | 0 | 0 | 0 | For |
| American Century | 93,085 | 0 | 0 | 0 | For |
| Global X | 75,363 | 0 | 0 | 0 | For |
| Brighthouse | 40,548 | 0 | 16,878 | 0 | For |
| AIG/SunAmerica | 55,259 | 0 | 0 | 0 | For |
| Northern Trust | 53,735 | 0 | 0 | 0 | For |
| Putnam | 53,024 | 0 | 0 | 0 | For |
| John Hancock | 46,340 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 44,762 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 42,933 | 0 | 0 | 0 | For |
Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.
Meeting held 2025-06-04.
Combines 2 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
NOVOCURE LTD.’s own tally for this item (“Elect Director: Martin Madden”): 82,199,569 for, 497,393 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 111,482,600 outstanding shares: 74% for, 0.5% against (74% of the company cast a for/against vote).
The 61 asset managers below cast 99.9% of the shares they voted on this item FOR (46,191,085 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 13,635,991 | 0 | 0 | 0 | For |
| Fidelity | 11,071,645 | 0 | 0 | 0 | For |
| Vanguard | 10,899,399 | 0 | 0 | 0 | For |
| BlackRock | 6,352,641 | 0 | 0 | 0 | For |
| Charles Schwab | 817,862 | 0 | 0 | 0 | For |
| TIAA | 562,136 | 0 | 0 | 0 | For |
| T. Rowe Price | 324,424 | 0 | 0 | 0 | For |
| Equitable | 307,448 | 0 | 0 | 0 | For |
| State Street | 185,151 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 181,491 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 164,792 | 0 | 0 | 0 | For |
| Lincoln Financial | 145,820 | 0 | 0 | 0 | For |
| Principal | 125,069 | 0 | 0 | 0 | For |
| Federated Hermes | 120,195 | 0 | 0 | 0 | For |
| DWS | 112,506 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 105,000 | 0 | 0 | 0 | For |
| American Century | 93,085 | 0 | 0 | 0 | For |
| Global X | 75,363 | 0 | 0 | 0 | For |
| Brighthouse | 40,548 | 0 | 16,878 | 0 | For |
| AIG/SunAmerica | 55,259 | 0 | 0 | 0 | For |
| Northern Trust | 53,735 | 0 | 0 | 0 | For |
| Putnam | 53,024 | 0 | 0 | 0 | For |
| John Hancock | 46,340 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 44,762 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 42,933 | 0 | 0 | 0 | For |
Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.
Meeting held 2025-06-04.
Combines 2 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
NOVOCURE LTD.’s own tally for this item (“Elect Director: Allyson Ocean”): 82,147,906 for, 527,676 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 111,482,600 outstanding shares: 74% for, 0.5% against (74% of the company cast a for/against vote).
The 61 asset managers below cast 99.9% of the shares they voted on this item FOR (46,191,085 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 13,635,991 | 0 | 0 | 0 | For |
| Fidelity | 11,071,645 | 0 | 0 | 0 | For |
| Vanguard | 10,899,399 | 0 | 0 | 0 | For |
| BlackRock | 6,352,641 | 0 | 0 | 0 | For |
| Charles Schwab | 817,862 | 0 | 0 | 0 | For |
| TIAA | 562,136 | 0 | 0 | 0 | For |
| T. Rowe Price | 324,424 | 0 | 0 | 0 | For |
| Equitable | 307,448 | 0 | 0 | 0 | For |
| State Street | 185,151 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 181,491 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 164,792 | 0 | 0 | 0 | For |
| Lincoln Financial | 145,820 | 0 | 0 | 0 | For |
| Principal | 125,069 | 0 | 0 | 0 | For |
| Federated Hermes | 120,195 | 0 | 0 | 0 | For |
| DWS | 112,506 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 105,000 | 0 | 0 | 0 | For |
| American Century | 93,085 | 0 | 0 | 0 | For |
| Global X | 75,363 | 0 | 0 | 0 | For |
| Brighthouse | 40,548 | 0 | 16,878 | 0 | For |
| AIG/SunAmerica | 55,259 | 0 | 0 | 0 | For |
| Northern Trust | 53,735 | 0 | 0 | 0 | For |
| Putnam | 53,024 | 0 | 0 | 0 | For |
| John Hancock | 46,340 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 44,762 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 42,933 | 0 | 0 | 0 | For |
Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.
Meeting held 2025-06-04.
Combines 2 wordings of this item as funds reported it.
99.4% Majority: yes · of votes cast
NOVOCURE LTD.’s own tally for this item (“Elect Director: Timothy Scannell”): 82,199,320 for, 495,578 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 111,482,600 outstanding shares: 74% for, 0.5% against (74% of the company cast a for/against vote).
The 61 asset managers below cast 99.9% of the shares they voted on this item FOR (46,191,085 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 13,635,991 | 0 | 0 | 0 | For |
| Fidelity | 11,071,645 | 0 | 0 | 0 | For |
| Vanguard | 10,899,399 | 0 | 0 | 0 | For |
| BlackRock | 6,352,641 | 0 | 0 | 0 | For |
| Charles Schwab | 817,862 | 0 | 0 | 0 | For |
| TIAA | 562,136 | 0 | 0 | 0 | For |
| T. Rowe Price | 324,424 | 0 | 0 | 0 | For |
| Equitable | 307,448 | 0 | 0 | 0 | For |
| State Street | 185,151 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 181,491 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 164,792 | 0 | 0 | 0 | For |
| Lincoln Financial | 145,820 | 0 | 0 | 0 | For |
| Principal | 125,069 | 0 | 0 | 0 | For |
| Federated Hermes | 120,195 | 0 | 0 | 0 | For |
| DWS | 112,506 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 105,000 | 0 | 0 | 0 | For |
| American Century | 93,085 | 0 | 0 | 0 | For |
| Global X | 75,363 | 0 | 0 | 0 | For |
| Brighthouse | 40,548 | 0 | 16,878 | 0 | For |
| AIG/SunAmerica | 55,259 | 0 | 0 | 0 | For |
| Northern Trust | 53,735 | 0 | 0 | 0 | For |
| Putnam | 53,024 | 0 | 0 | 0 | For |
| John Hancock | 46,340 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 44,762 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 42,933 | 0 | 0 | 0 | For |
Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.
Meeting held 2025-06-04.
Combines 2 wordings of this item as funds reported it.
99.4% Majority: yes · of votes cast
NOVOCURE LTD.’s own tally for this item (“Elect Director: Kristin Stafford”): 82,206,597 for, 490,733 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 111,482,600 outstanding shares: 74% for, 0.5% against (74% of the company cast a for/against vote).
The 61 asset managers below cast 99.9% of the shares they voted on this item FOR (46,191,085 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 13,635,991 | 0 | 0 | 0 | For |
| Fidelity | 11,071,645 | 0 | 0 | 0 | For |
| Vanguard | 10,899,399 | 0 | 0 | 0 | For |
| BlackRock | 6,352,641 | 0 | 0 | 0 | For |
| Charles Schwab | 817,862 | 0 | 0 | 0 | For |
| TIAA | 562,136 | 0 | 0 | 0 | For |
| T. Rowe Price | 324,424 | 0 | 0 | 0 | For |
| Equitable | 307,448 | 0 | 0 | 0 | For |
| State Street | 185,151 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 181,491 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 164,792 | 0 | 0 | 0 | For |
| Lincoln Financial | 145,820 | 0 | 0 | 0 | For |
| Principal | 125,069 | 0 | 0 | 0 | For |
| Federated Hermes | 120,195 | 0 | 0 | 0 | For |
| DWS | 112,506 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 105,000 | 0 | 0 | 0 | For |
| American Century | 93,085 | 0 | 0 | 0 | For |
| Global X | 75,363 | 0 | 0 | 0 | For |
| Brighthouse | 40,548 | 0 | 16,878 | 0 | For |
| AIG/SunAmerica | 55,259 | 0 | 0 | 0 | For |
| Northern Trust | 53,735 | 0 | 0 | 0 | For |
| Putnam | 53,024 | 0 | 0 | 0 | For |
| John Hancock | 46,340 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 44,762 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 42,933 | 0 | 0 | 0 | For |
Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.
Meeting held 2025-06-04.
Combines 2 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
NOVOCURE LTD.’s own tally for this item (“Elect Director: William Vernon”): 81,646,756 for, 1,048,764 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 111,482,600 outstanding shares: 73% for, 1.0% against (74% of the company cast a for/against vote).
The 61 asset managers below cast 99.8% of the shares they voted on this item FOR (46,118,518 for, 72,567 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 13,635,991 | 0 | 0 | 0 | For |
| Fidelity | 11,071,645 | 0 | 0 | 0 | For |
| Vanguard | 10,899,399 | 0 | 0 | 0 | For |
| BlackRock | 6,352,641 | 0 | 0 | 0 | For |
| Charles Schwab | 817,862 | 0 | 0 | 0 | For |
| TIAA | 562,136 | 0 | 0 | 0 | For |
| T. Rowe Price | 324,424 | 0 | 0 | 0 | For |
| Equitable | 307,448 | 0 | 0 | 0 | For |
| State Street | 185,151 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 181,491 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 164,792 | 0 | 0 | 0 | For |
| Lincoln Financial | 145,820 | 0 | 0 | 0 | For |
| Principal | 125,069 | 0 | 0 | 0 | For |
| Federated Hermes | 120,195 | 0 | 0 | 0 | For |
| DWS | 112,506 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 105,000 | 0 | 0 | 0 | For |
| American Century | 93,085 | 0 | 0 | 0 | For |
| Global X | 75,363 | 0 | 0 | 0 | For |
| Brighthouse | 40,548 | 0 | 16,878 | 0 | For |
| AIG/SunAmerica | 55,259 | 0 | 0 | 0 | For |
| Northern Trust | 53,735 | 0 | 0 | 0 | For |
| Putnam | 53,024 | 0 | 0 | 0 | For |
| John Hancock | 46,340 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 0 | 44,762 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 42,933 | 0 | 0 | 0 | For |
Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.
Meeting held 2025-06-04.
Combines 2 wordings of this item as funds reported it.
99% Passed · of votes cast
NOVOCURE LTD.’s own tally for this item (“Proposal 2: Ratification of Independent Registered Public Accounting Firm .”): 91,489,770 for, 1,216,673 against — passed, per its Form 8-K (Item 5.07). Of all 111,482,600 outstanding shares: 82% for, 1% against (83% of the company cast a for/against vote).
The 61 asset managers below cast 99.9% of the shares they voted on this item FOR (46,118,060 for, 46,135 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 13,635,991 | 0 | 0 | 0 | For |
| Fidelity | 11,071,645 | 0 | 0 | 0 | For |
| Vanguard | 10,898,507 | 892 | 0 | 0 | For |
| BlackRock | 6,352,641 | 0 | 0 | 0 | For |
| Charles Schwab | 817,862 | 0 | 0 | 0 | For |
| TIAA | 562,136 | 0 | 0 | 0 | For |
| T. Rowe Price | 324,424 | 0 | 0 | 0 | For |
| Equitable | 307,448 | 0 | 0 | 0 | For |
| State Street | 185,151 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 181,491 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 164,792 | 0 | 0 | 0 | For |
| Lincoln Financial | 145,820 | 0 | 0 | 0 | For |
| Principal | 125,069 | 0 | 0 | 0 | For |
| Federated Hermes | 120,195 | 0 | 0 | 0 | For |
| DWS | 112,506 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 105,000 | 0 | 0 | 0 | For |
| American Century | 93,085 | 0 | 0 | 0 | For |
| Global X | 75,363 | 0 | 0 | 0 | For |
| Brighthouse | 40,548 | 0 | 16,878 | 0 | For |
| AIG/SunAmerica | 55,259 | 0 | 0 | 0 | For |
| Northern Trust | 53,735 | 0 | 0 | 0 | For |
| Putnam | 53,024 | 0 | 0 | 0 | For |
| John Hancock | 46,340 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 0 | 44,762 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 42,933 | 0 | 0 | 0 | For |
Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.
Meeting held 2025-06-04.
98% Passed · of votes cast
NOVOCURE LTD.’s own tally for this item (“Proposal 3: Approval of a non-binding advisory vote to approve executive compensation .”): 80,626,467 for, 2,042,002 against — passed, per its Form 8-K (Item 5.07). Of all 111,482,600 outstanding shares: 72% for, 2% against (74% of the company cast a for/against vote).
The 7 asset managers below cast 99.3% of the shares they voted on this item FOR (171,939 for, 1,135 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JPMorgan | 89,335 | 0 | 0 | 0 | For |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 55,373 | 0 | 0 | 0 | For |
| HC CAPITAL TRUST | 26,890 | 0 | 0 | 0 | For |
| Desjardins Global Asset Management Inc. | 0 | 1,135 | 0 | 0 | Against |
| TD ASSET MANAGEMENT INC | 291 | 0 | 0 | 0 | For |
| Coyle Financial Counsel LLC | 25 | 0 | 0 | 0 | For |
| SIERRA SUMMIT ADVISORS LLC | 25 | 0 | 0 | 0 | For |
Meeting held 2024-06-05 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).
Combines 3 wordings of this item as funds reported it.
98% Passed · of votes cast
NOVOCURE LTD.’s own tally for this item (“Proposal 3: Approval of a non-binding advisory vote to approve executive compensation .”): 69,640,399 for, 1,248,234 against — passed, per its Form 8-K (Item 5.07). Of all 111,482,600 outstanding shares: 62% for, 1% against (64% of the company cast a for/against vote).
The 3 asset managers below cast 100% of the shares they voted on this item FOR (430 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| COLDSTREAM CAPITAL MANAGEMENT INC | 340 | 0 | 0 | 0 | For |
| Cox Capital Mgt LLC | 90 | 0 | 0 | 0 | For |
| Echo45 Advisors LLC | 0 | 0 | 0 | 0 | -- |
Ranked by the number of NOVOCURE LTD. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 111,482,600 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Capital Group | 24.94% |
| 2 | Fidelity | 24.72% |
| 3 | BlackRock | 11.44% |
| 4 | Vanguard | 10.14% |
| 5 | Soleus Capital Management, L.P. | 4.89% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 2.22% |
| 7 | State Street | 2.12% |
| 8 | Charles Schwab | 1.47% |
| 9 | Northern Trust | 1.05% |
| 10 | Palo Alto Investors LP | 0.86% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| FMR (Fidelity) | 14.79% | 13F |
| BlackRock | 11.69% | 13F |
| Vanguard Group | 10.09% | 13F |
| Soleus Capital Master Fund, L.P. | 9.41% | 13G |
| State Street | 2.32% | 13F |
| Geode Capital | 2.21% | 13F |
| Northern Trust | 1.11% | 13F |
| Goldman Sachs | 0.89% | 13F |
| Charles Schwab | 0.73% | 13F |
| Renaissance Technologies | 0.69% | 13F |
Percentages above are of 111,482,600 shares outstanding, as reported by NOVOCURE LTD. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from NOVOCURE LTD.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.
At NOVOCURE LTD.'s shareholder meeting held 2025-06-04, in the 2024-2025 proxy season, 273 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,078 separate fund positions. Their filings are grouped here into 16 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — A non-binding advisory vote to approve executive compensation. — the proposal passed with 98% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: NOVOCURE LTD.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission (filing date not recorded for this item).
NOVOCURE LTD. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.